Particle.news
Download on the App Store

Tatiana Schlossberg Discloses Terminal AML Diagnosis in New Yorker Essay

Her account describes a rare, treatment‑resistant leukemia with a prognosis of about a year.

Overview

  • Doctors detected acute myeloid leukemia hours after her May 2024 delivery when a lab showed a white‑blood‑cell count of 131,000 per microliter.
  • The disease involves the uncommon Inversion 3 mutation, which is associated with poor response to standard therapies.
  • Her treatment has included chemotherapy, two stem‑cell transplants (the first from her sister, Rose), CAR‑T therapy and multiple clinical trials, followed by relapse.
  • Complications have included an Epstein–Barr virus infection that damaged her kidneys, extended hospitalizations and rehabilitation to walk again.
  • She praises her family’s caregiving and faults HHS Secretary Robert F. Kennedy Jr. for research funding cuts, while noting federal actions that temporarily jeopardized Columbia’s funding before it was restored.